228 related articles for article (PubMed ID: 26706938)
1. Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients.
Lu J; Van Stappen T; Spasic D; Delport F; Vermeire S; Gils A; Lammertyn J
Biosens Bioelectron; 2016 May; 79():173-9. PubMed ID: 26706938
[TBL] [Abstract][Full Text] [Related]
2. Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor.
Lu J; Spasic D; Delport F; Van Stappen T; Detrez I; Daems D; Vermeire S; Gils A; Lammertyn J
Anal Chem; 2017 Mar; 89(6):3664-3671. PubMed ID: 28222600
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays.
Van Stappen T; Brouwers E; Tops S; Geukens N; Vermeire S; Declerck PJ; Gils A
Ther Drug Monit; 2015 Aug; 37(4):479-85. PubMed ID: 25525757
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Quantum Blue® reader Point-of-Care system versus ELISA technique for therapeutic drug monitoring of Infliximab levels.
Novakovic V; Abdija S; Larsen PB; Fenger M; Gredal L; Jacobsen KK
Clin Biochem; 2019 Dec; 74():73-75. PubMed ID: 31669514
[TBL] [Abstract][Full Text] [Related]
5. Surface plasmon resonance assays for the therapeutic drug monitoring of infliximab indicate clinical relevance of anti-infliximab antibody binding properties.
Grasmeier MK; Weber S; Treiber M; Thaler MA; Luppa PB
Clin Chem Lab Med; 2023 Jun; 61(7):1255-1265. PubMed ID: 36753693
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
Bian S; Lu J; Delport F; Vermeire S; Spasic D; Lammertyn J; Gils A
Drug Test Anal; 2018 Mar; 10(3):592-596. PubMed ID: 28743169
[TBL] [Abstract][Full Text] [Related]
7. FO-SPR biosensor calibrated with recombinant extracellular vesicles enables specific and sensitive detection directly in complex matrices.
Yildizhan Y; Vajrala VS; Geeurickx E; Declerck C; Duskunovic N; De Sutter D; Noppen S; Delport F; Schols D; Swinnen JV; Eyckerman S; Hendrix A; Lammertyn J; Spasic D
J Extracell Vesicles; 2021 Feb; 10(4):e12059. PubMed ID: 33664936
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
Marini JC; Sendecki J; Cornillie F; Popp JW; Black S; Blank M; Gils A; Van Stappen T; Hamann D; Rispens T; Thérien L; Chun K; Shankar G
AAPS J; 2017 Jan; 19(1):161-171. PubMed ID: 27600137
[TBL] [Abstract][Full Text] [Related]
9. Co(III)-NTA Mediated Antigen Immobilization on a Fiber Optic-SPR Biosensor for Detection of Autoantibodies in Autoimmune Diseases: Application in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Horta S; Qu JH; Dekimpe C; Bonnez Q; Vandenbulcke A; Tellier E; Kaplanski G; Delport F; Geukens N; Lammertyn J; Vanhoorelbeke K
Anal Chem; 2020 Oct; 92(20):13880-13887. PubMed ID: 32929962
[TBL] [Abstract][Full Text] [Related]
10. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Afonso J; Lopes S; Gonçalves R; Caldeira P; Lago P; Tavares de Sousa H; Ramos J; Gonçalves AR; Ministro P; Rosa I; Vieira AI; Dias CC; Magro F;
Aliment Pharmacol Ther; 2016 Oct; 44(7):684-92. PubMed ID: 27507790
[TBL] [Abstract][Full Text] [Related]
11. Expanding a Portfolio of (FO-) SPR Surface Chemistries with the Co(III)-NTA Oriented Immobilization of His
Qu JH; Horta S; Delport F; Sillen M; Geukens N; Sun DW; Vanhoorelbeke K; Declerck P; Lammertyn J; Spasic D
ACS Sens; 2020 Apr; 5(4):960-969. PubMed ID: 32216277
[TBL] [Abstract][Full Text] [Related]
12. Infliximab trough levels: A comparison between the Quantum Blue Infliximab assay and the established ELISA.
Lim MH; Aluzaite K; Schultz M; Casey P
J Gastroenterol Hepatol; 2020 Aug; 35(8):1302-1306. PubMed ID: 31881552
[TBL] [Abstract][Full Text] [Related]
13. Determination of Serum Infliximab Concentration by Point-of-care Devices in Children With Inflammatory Bowel Disease.
Curci D; Lucafò M; Cifù A; Bramuzzo M; Martelossi S; Favretto D; De Pellegrin F; Fabris M; Vascotto F; Naviglio S; Ventura A; Stocco G; Decorti G
J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):474-479. PubMed ID: 31149938
[TBL] [Abstract][Full Text] [Related]
14. An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases.
Van Stappen T; Billiet T; Vande Casteele N; Compernolle G; Brouwers E; Vermeire S; Gils A
Inflamm Bowel Dis; 2015 Sep; 21(9):2172-7. PubMed ID: 26284296
[TBL] [Abstract][Full Text] [Related]
15. Integrated Signal Amplification on a Fiber Optic SPR Sensor Using Duplexed Aptamers.
Dillen A; Scarpellini C; Daenen W; Driesen S; Zijlstra P; Lammertyn J
ACS Sens; 2023 Feb; 8(2):811-821. PubMed ID: 36734337
[TBL] [Abstract][Full Text] [Related]
16. A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study.
Corstjens PL; Fidder HH; Wiesmeijer KC; de Dood CJ; Rispens T; Wolbink GJ; Hommes DW; Tanke HJ
Anal Bioanal Chem; 2013 Sep; 405(23):7367-75. PubMed ID: 23836086
[TBL] [Abstract][Full Text] [Related]
17. Significance of low level infliximab in the absence of anti-infliximab antibodies.
Ungar B; Anafy A; Yanai H; Ron Y; Yavzori M; Picard O; Fudim E; Loebstein R; Kopylov U; Chowers Y; Dotan I; Eliakim R; Ben-Horin S
World J Gastroenterol; 2015 Feb; 21(6):1907-14. PubMed ID: 25684959
[TBL] [Abstract][Full Text] [Related]
18. A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum.
Zeni L; Perri C; Cennamo N; Arcadio F; D'Agostino G; Salmona M; Beeg M; Gobbi M
Sci Rep; 2020 Jul; 10(1):11154. PubMed ID: 32636434
[TBL] [Abstract][Full Text] [Related]
19. Fast and accurate peanut allergen detection with nanobead enhanced optical fiber SPR biosensor.
Pollet J; Delport F; Janssen KP; Tran DT; Wouters J; Verbiest T; Lammertyn J
Talanta; 2011 Feb; 83(5):1436-41. PubMed ID: 21238733
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical performance evaluation of two POC tests for therapeutic drug monitoring of infliximab.
Van den Bossche D; De Smet D; Debrabandere J; Vanpoucke H
Clin Chem Lab Med; 2019 May; 57(6):856-863. PubMed ID: 30838834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
